These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29692590)

  • 1. Hemolysis area: A new parameter of erythrocyte osmotic fragility for screening of thalassemia trait.
    Tatu T; Sweatman D
    J Lab Physicians; 2018; 10(2):214-220. PubMed ID: 29692590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Values of MCV,MCH,ROFT and HbA
    Liu Y; Lin XY; Huang Y; Huang QW; Chen HL; Shen MN; Ruan JY; Li XY; Xu LH; Fang JP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1679-1682. PubMed ID: 33067973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the accuracy of the corpuscular fragility and mean corpuscular volume tests for the alpha-thalassemia 1 and beta-thalassemia traits.
    Sirichotiyakul S; Wanapirak C; Srisupundit K; Luewan S; Tongsong T
    Int J Gynaecol Obstet; 2009 Oct; 107(1):26-9. PubMed ID: 19591999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hb E (HBB: c.79G>A), Mean Corpuscular Volume, Mean Corpuscular Hemoglobin Cutoff Points in Double Heterozygous Hb E/- -
    Leckngam P; Limweeraprajak E; Kiewkarnkha T; Tatu T
    Hemoglobin; 2017 Jan; 41(1):38-43. PubMed ID: 28413893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte Indices and Hemoglobin Analysis for α-Thalassemia Screening in an Area with High Carrying Rate.
    Zheng L; Huang H; Wu X; Shen Q; Chen M; Wang M; Su L; Xu L
    Indian J Hematol Blood Transfus; 2022 Apr; 38(2):352-358. PubMed ID: 35496953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the effect of three β-thalassemia prenatal screening strategies using in Guangdong province].
    Li B; Yin A; Luo M; Wu L; Ma Y; Wang X; Zhang X; Zhao Q
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):434-40. PubMed ID: 26311551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Using Mean Corpuscular Volume and Mean Corpuscular Hemoglobin for Beta-thalassemia Carrier Screening in the Guangdong Population of China.
    Gu H; Wang YX; Du MX; Xu SS; Zhou BY; Li MZ
    Biomed Environ Sci; 2021 Aug; 34(8):667-671. PubMed ID: 34474730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal cutoff of mean corpuscular volume (MCV) for screening of alpha-thalassemia 1 trait.
    Nunchai C; Sirichotiyakul S; Tongsong T
    J Obstet Gynaecol Res; 2020 May; 46(5):774-778. PubMed ID: 32077202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective screening for double heterozygosity of Hb E/alpha0-thalassemia.
    Sanchaisuriya K; Chirakul S; Srivorakun H; Fucharoen G; Fucharoen S; Changtrakul Y; Sanchaisuriya P
    Ann Hematol; 2008 Nov; 87(11):911-4. PubMed ID: 18575861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of premarital screening of beta-thalassemia trait using MCH rather than MCV in the population of Fars Province, Iran.
    Karimi M; Rasekhi AR
    Haematologia (Budap); 2002; 32(2):129-33. PubMed ID: 12412732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic Cut-Off Value of RDW for Screening Thalassemia and the Combined Determination of MCV, MCH, HBA
    Song QL; Guo YL; He YJ; He C; Zhang T; Cai Y; Liu W; Zhu XC; Liu QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):847-852. PubMed ID: 34105482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and diagnosis of Hb Quong Sze [HBA2: c.377T > C (or HBA1)] in a prenatal control program for thalassemia.
    Yang Y; Lou JW; Liu YH; He Y; Li DZ
    Hemoglobin; 2014; 38(3):158-60. PubMed ID: 24826791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte indices in a large cohort of β-thalassemia carrier: Implication for population screening in an area with high prevalence and heterogeneity of thalassemia.
    Singha K; Taweenan W; Fucharoen G; Fucharoen S
    Int J Lab Hematol; 2019 Aug; 41(4):513-518. PubMed ID: 31099487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Values of Hematological Indicators in the Screening of α-Thalassemia in Fujian Area of China].
    Xie YP; Cao YP; Zhu XJ; Liu HJ; Liu J; Zhou WJ; Lu PX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):165-169. PubMed ID: 30738464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte osmotic fragility test for screening of alpha-thalassemia-1 and beta-thalassemia trait in pregnancy.
    Sirichotiyakul S; Tantipalakorn C; Sanguansermsri T; Wanapirak C; Tongsong T
    Int J Gynaecol Obstet; 2004 Sep; 86(3):347-50. PubMed ID: 15325851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematological Parameters in Individuals with Beta Thalassemia Trait in South Sumatra, Indonesia.
    Sari DP; Wahidiyat PA; Setianingsih I; Timan IS; Gatot D; Kekalih A
    Anemia; 2022; 2022():3572986. PubMed ID: 35573052
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Boras MM; Kvesić K; Talić S; Pušić D
    Ann Clin Lab Sci; 2024 Jan; 54(1):121-125. PubMed ID: 38514053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of screening tools to differentiate beta thalassemia trait and iron-deficiency anemia - do they serve a purpose in blood donors?
    Sundh A; Kaur P; Palta A; Kaur G
    Blood Res; 2020 Sep; 55(3):169-174. PubMed ID: 32989178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of mean corpuscular hemoglobin (MCH): for screening alpha-thalassemia-1 trait and beta-thalassemia trait.
    Pranpanus S; Sirichotiyakul S; Srisupundit K; Tongsong T
    J Med Assoc Thai; 2009 Jun; 92(6):739-43. PubMed ID: 19530577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive screening for coexisting heterozygous α
    Polprasert C; Wongprachar P; Suksusut A; Settapiboon R; Amornsirivat S; Sophonphan J; Uaprasert N; Sucharitchan P; Rojnuckarin P
    Hematology; 2020 Dec; 25(1):276-279. PubMed ID: 32633642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.